Browse > Article
http://dx.doi.org/10.5142/jgr.2011.35.3.301

Metabolic Activities of Ginseng and Its Constituents, Ginsenoside Rb1 and Rg1, by Human Intestinal Microflora  

Choi, Jong-Ryul (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University)
Hong, Sung-Woon (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University)
Kim, Yu-Ri (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University)
Jang, Se-Eun (Department of Food and Nutrition, Kyung Hee University)
Kim, Nam-Jae (East-West Medical Research Institute, Kyung Hee University)
Han, Myung-Joo (Department of Food and Nutrition, Kyung Hee University)
Kim, Dong-Hyun (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University)
Publication Information
Journal of Ginseng Research / v.35, no.3, 2011 , pp. 301-307 More about this Journal
Abstract
To evaluate the difference in expressing pharmacological effects of ginseng by intestinal microflora between Koreans, metabolic activities of ginseng, ginsenoside $Rb_1$ and $Rg_1$ by 100 fecal specimens were measured. The ${\beta}$-glucosidase activity for p-nitrophenyl-${\beta}$-D-glucopyranoside was 0 to 0.42 mmol/min/mg and its average activity (mean${\pm}$SD) was $0.10{\pm}0.07$ mmol/min/mg. The metabolic activities of ginsenosides Rb1 and Rg1 were 0.01 to 0.42 and 0.01 to 0.38 pmol/min/mg, respectively. Their average activities were $0.25{\pm}0.08$ and $0.15{\pm}0.09$ pmol/min/mg, respectively. The compound K-forming activities from ginsenoside Rb1 and ginseng extract were 0 to 0.11 and 0 to 0.02 pmol/min/mg, respectively. Their average compound K-forming activities were $0.24{\pm}0.09$ pmol/min/ mg and $2.14{\pm}3.66$ fmol/min/mg, respectively. These activities all were not different between males and females, or between ages. Although compound K-forming activity from the aqueous extract of ginseng was low compared to that from ginenoside $Rb_1$, their profiles were similar to those of isolated compounds. Based on these findings, we believe that the intestinal bacterial metabolic activities of ginseng components are variable in individuals and may be used as selection markers for responders to ginseng.
Keywords
Intestinal microflora; Metabolism; Ginsenoside $Rb_1$; Ginsenoside $Rg_1$; Pharmacological effect;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By Web Of Science : 5  (Related Records In Web of Science)
연도 인용수 순위
1 Kobashi K, Akao T. Relation of intestinal bacteria to pharmacological effect of glycosides. Biosci Microflora 1997; 16:1-7.   DOI
2 Kim DH. Intestinal microflora activate the pharmacological effects of herbal medicines. Nat Prod Sci 2002;8:35- 43.
3 Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol 1998;50:1155-1160.   DOI   ScienceOn
4 Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Inst 1980;64:255-261.   DOI
5 Ling WH, Korpela R, Mykkanen H, Salminen S, Hanninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 1994;124:18-23.   DOI
6 Kim DH. The possible role of intestinal microflora in pharmacological activities of ginseng. Int J Biomed Pharm Sci 2011; in press.
7 Reddy BS, Hanson D, Mangat S, Mathews L, Sbaschnig M, Sharma C, Simi B. Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J Nutr 1980;110:1880-1887.   DOI
8 Lee DS, Kim YS, Ko CN, Cho KH, Bae HS, Lee KS, Kim JJ, Park EK, Kim DH. Fecal metabolic activities of herbal components to bioactive compounds. Arch Pharm Res 2002;25:165-169.   DOI   ScienceOn
9 Yim JS, Kim YS, Moon SK, Cho KH, Bae HS, Kim JJ, Park EK, Kim DH. Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol Pharm Bull 2004;27:1580-1583.   DOI   ScienceOn
10 Mallet AK, Rowland IR, Bearne CA, Flynn JC, Fehilly BT, Udeen YS, Farthing MJ. Effect of dietary supplements of apple pectin, wheat bran or fat on the enzyme activity of the human faecal flora. Microb Ecol Health Dis 1988;1:23-39.   DOI
11 Rumney CJ, Rowland IR. In vivo and in vitro models of the human colonic flora. Crit Rev Food Sci Nutr 1992;31:299-331.   DOI   ScienceOn
12 Mykkanen H, Laiho K, Salminen S. Variations in faecal bacterial enzyme activities and associations with bowel function and diet in elderly subjects. J Appl Microbiol 1998;85:37-41.   DOI   ScienceOn
13 Ikeda N, Saito Y, Shimizu J, Ochi A, Mizutani J, Watabe J. Variations in concentrations of bacterial metabolites, enzyme activities, moisture, pH and bacterial composition between and within individuals in faeces of seven healthy adults. J Appl Bacteriol 1994;77:185-194.   DOI   ScienceOn
14 Bae EA, Park SY, Kim DH. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull 2000;23:1481-1485.   DOI   ScienceOn
15 Simon GL, Gorbach SL. The human intestinal microflora. Dig Dis Sci 1986;31(9 Suppl):147S-162S.   DOI
16 Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration- -measurement of compound K by enzyme immunoassay. Biol Pharm Bull 1998;21:245-249.   DOI   ScienceOn
17 Lee J, Lee E, Kim D, Lee J, Yoo J, Koh B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J Ethnopharmacol 2009;122:143-148.   DOI   ScienceOn
18 Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem Biophys Res Commun 1998;246:725-730.   DOI   ScienceOn
19 Choo MK, Park EK, Han MJ, Kim DH. Antiallergic activity of ginseng and its ginsenosides. Planta Med 2003;69:518-522.   DOI   ScienceOn
20 Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 2002;25:743-747.   DOI   ScienceOn
21 Bae EA, Kim NY, Han MJ, Choo MK, Kim DH. Transformation of ginsenosides to compound K (IH-901) by lactic acid bacteria of human intestine. J Microbiol Biotechnol 2003;13:9-14.
22 Kobashi K, Nakata H, Takebe H, Terasawa K. Relation of intestinal microflora to Syo. Wakan-iyaku-kaishi 1984;1:166-167.
23 Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res 2004;27:61-67.   DOI   ScienceOn
24 Kim YS, Kim JJ, Cho KH, Jung WS, Moon SK, Park EK, Kim DH. Biotransformation of ginsenoside $Rb_{1}$, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. J Microbiol Biotechnol 2008;18:1109-1114.